Similar articles

• Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.

  Glueck CJ, Tsang RC, Fallat RW, Scheel D. Glueck CJ, et al. Pediatrics. 1974 Jul;54(1):51-5. Pediatrics. 1974. PMID: 4365953 No abstract available.
• Dietary and drug treatment of primary hyperlipoproteinemia.

  [No authors listed] [No authors listed] Ann Intern Med. 1972 Aug;77(2):267-94. doi: 10.7326/0003-4819-77-2-267. Ann Intern Med. 1972. PMID: 4345081 Review. No abstract available.
• [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].

  Sauvanet JP, Drouin P, Mejean L, Lambert D, Debry G. Sauvanet JP, et al. Therapie. 1978 Sep-Oct;33(5):615-22. Therapie. 1978. PMID: 217121 French. No abstract available.
• The primary hyperlipoproteinemias.

  Bybee DE, Hamilton RD. Bybee DE, et al. J Ky Med Assoc. 1974 Dec;72(12):658-62. J Ky Med Assoc. 1974. PMID: 4373515 Review. No abstract available.
• Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.

  Glueck CJ, Tsang RC, Fallat RW, Mellies M. Glueck CJ, et al. Pediatrics. 1977 Mar;59(3):433-41. Pediatrics. 1977. PMID: 840563